Delivery Order SPE2DB22D1202-SPE2DB24FUWC6
- Not listed
- This federal contract award is for the pharmaceutical product Dupixent 200 mg/1.14 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office division. The $3,215.43 firm-fixed-price delivery order was issued by the Defense agency Medical Supply Chain, with a performance location in Conshohocken, Pennsylvania. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $9,664.07 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order (SPE2DB22D1106|SPE2DB24FEER2) from the Defense Logistics Agency (DLA) Troop Support Medical worth $48,548.37. The award is for the supply of a pharmaceutical product, Dupixent 300 mg/2 ml pen, to support military treatment programs and facilities. This is not a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen 2ml to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The $29,013.39 Firm Fixed Price delivery order contract has an ultimate completion date of April 18, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $32,672.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of August 2, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States, providing a wide range of medical commodities to federal agencies and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,881.42 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $2,257.96, is for the supply of Dupixent 300 mg/2 ml pens. The contract is a firm fixed price delivery order with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,980.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of Dupixent 300 mg/2 ml syringes to the U.S. Department of Defense through the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price contract, with a ceiling value of $27,393.03, has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $5,505.59 for the supply of the pharmaceutical product Dupixent. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUWC6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of a pharmaceutical product, Dupixent 300 mg/2 ml pen 2 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed price delivery order with a ceiling value of $8,490.16 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 4/8/24 |